Skip to content
The Nexus
DossierENTITY

Pakistan-China Pharmaceutical and Healthcare B2B Investment Conference

Coverage of Pakistan-China Pharmaceutical and Healthcare B2B Investment Conference in the Nexus archive.

Earliest in view: Jul 19 · 02:43 UTCMost recent: Jul 19 · 02:43 UTC
Co-mentioned in this coverage
Mustafa Kamalperson1Federal Health Ministerperson1Chinese companiesorganization1Drug Regulatory Authority of Pakistanorganization1herbal medicinestopic1local vaccine productiontopic1pharmaceutical raw materialstopic1
Recent coverage
  • HEALTHJul 19 · 02:43 UTCDAWN
    Pakistan-China pharma conference ends with $850m agreements

    Pakistan and China finalized $850 million in agreements during a pharmaceutical conference, including 16 contracts and 80 MoUs, with 18 deals focused on herbal medicines. The agreements aim to boost local production of health equipment, raw materials, and vaccines, reducing imports and foreign exchange costs.

Pakistan-China Pharmaceutical and Healthcare B2B Investment Conference · Dossier · The Nexus